Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on May 1, 2025
Eleos Advances Comprehensive Behavioral Health Product Capabilities
GlobeNewswire
·
May 1, 2025
The new Eleos Documentation experience brings industry-leading augmented intelligence tools to more behavioral health use cases, 150+ languages, and rural or offline care settings Eleos dives deeper into Spring product updates and AI governance and …
Canadians Come Together in Support of People Living with Multiple Sclerosis this MS Awareness Month
GlobeNewswire
·
May 1, 2025
Toronto, ON, May 01, 2025 (GLOBE NEWSWIRE) -- May is MS Awareness Month and MS Canada invites all Canadians to come together in raising awareness and funds in support of people affected by multiple sclerosis (MS). On average, 12 Canadians are diagnosed …
Dupixent® (dupilumab) Data Presented at ATS Reinforce Impact of Targeting Key Type 2 Inflammation Drivers to Improve Outcomes for Chronic Respiratory Diseases
GlobeNewswire
·
May 1, 2025
24 abstracts, including 1 oral presentation and 4 late-breaking posters on Dupixent, to showcase new clinical and real-world analyses in chronic obstructive pulmonary disease (COPD) and asthma COPD data from the landmark Phase 3 trials will highlight …
BioCardia Announces First Patient in Phase 3 Randomized Controlled Double-Blind CardiAMP HF II Clinical Trial of the Company’s Lead Cell Therapy for Treatment of Heart Failure
GlobeNewswire
·
May 1, 2025
SUNNYVALE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [NASDAQ: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the first patient enrolled in the …
Resmed Acquires VirtuOx
GlobeNewswire
·
May 1, 2025
SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced it has acquired VirtuOx, a leading independent diagnostic testing …
Scilex Holding Company to Present Post-Hoc Analysis of the C.L.E.A.R. Trial on Clinical Meaningfulness of Safety and Efficacy of SP-102 for the Treatment of Lumbosacral Radicular Pain (LRP) at the 27th Annual Meeting of American Society of…
GlobeNewswire
·
May 1, 2025
PALO ALTO, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the …
Promex Industries Expands Best-in-Class Capabilities, Installing Laser Depaneling and Advanced SPI Systems on Manufacturing Line
GlobeNewswire
·
May 1, 2025
SANTA CLARA, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Promex Industries, Inc., a Silicon Valley-based provider of advanced design, packaging, and microelectronics assembly services, today announced it has expanded its manufacturing line, adding two …
RoomSync Partners with Counslr to Launch the Fall Pass to Improve Community Well-being and Increase Revenue
GlobeNewswire
·
May 1, 2025
NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- Counslr, a leading digital mental health company, and RoomSync, the premier provider of roommate matching software, announced a strategic partnership to provide student residents access to on-demand mental health …
Akari Therapeutics Appoints Mark F. Kubik as Head of Business Development - Oncology
GlobeNewswire
·
May 1, 2025
Global expertise in establishing and executing transformative transactions which have led to multiple approved therapeutic products Successful track record across oncology therapeutics including ADCs and antibody therapies ranging from early discovery to …
Veru to Report Fiscal 2025 Second Quarter Financial Results on May 8
GlobeNewswire
·
May 1, 2025
MIAMI, May 01, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced it will host a …
Adial Pharmaceuticals Expands Intellectual Property Portfolio with New U.S. Patent Granted for Genetic-Based Treatment of Alcohol and Opioid Use Disorders
GlobeNewswire
·
May 1, 2025
GLEN ALLEN, Va., May 01, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related …
Wave Life Sciences First Quarter 2025 Financial Results Scheduled for May 8, 2025
GlobeNewswire
·
May 1, 2025
CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will host a live webcast and conference …
Palisade Bio’s AI-Driven Approach to IBD Heterogeneity and Efficacy Selected for Presentation at the 3rd Annual Precision Medicine in Inflammatory Bowel Disease Summit
GlobeNewswire
·
May 1, 2025
Carlsbad, CA, May 01, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with …
Extendicare Announces Agreement to Acquire Closing the Gap Healthcare Group
GlobeNewswire
·
May 1, 2025
MARKHAM, Ontario, May 01, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that its wholly owned home health care subsidiary, ParaMed Inc. (“ParaMed” or the “Purchaser”), has entered into an agreement to …
Windtree Announces Strategic Transaction to Drive Revenue Generation in Support of Ongoing Therapeutic Pipeline Development
GlobeNewswire
·
May 1, 2025
WARRINGTON, Pa., May 01, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on becoming a revenue generating company and advancing early and late-stage innovative therapies …
Kronos Bio Enters into Agreement to Be Acquired by Concentra Biosciences for $0.57 in Cash per Share Plus a Contingent Value Right
GlobeNewswire
·
May 1, 2025
CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. ("Kronos Bio") (Nasdaq: KRON), a biotechnology company that has been developing small molecule therapeutics to address cancers and other diseases driven by deregulated transcription, today …
4DMT Announces RMAT Designation Granted by FDA for 4D-150 for DME
GlobeNewswire
·
May 1, 2025
EMERYVILLE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment …
Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors
GlobeNewswire
·
May 1, 2025
SAN CARLOS, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today announced it has appointed Dr. …
ProQR Announces Annual General Meeting of Shareholders to be Held June 3, 2025
GlobeNewswire
·
May 1, 2025
LEIDEN, Netherlands …
BrainsWay to Showcase Deep TMS at the 2025 American Psychiatric Association Annual Meeting in Los Angeles
GlobeNewswire
·
May 1, 2025
BURLINGTON, Mass. and JERUSALEM, May 01, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ …